Overview of Reviews

You have free access to this content

Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews

  1. Christopher J Cates1,*,
  2. Marta Oleszczuk2,
  3. Elizabeth Stovold1,
  4. L. Susan Wieland3

Editorial Group: Cochrane Airways Group

Published Online: 17 OCT 2012

Assessed as up-to-date: 24 MAY 2012

DOI: 10.1002/14651858.CD010005.pub2


How to Cite

Cates CJ, Oleszczuk M, Stovold E, Wieland LS. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD010005. DOI: 10.1002/14651858.CD010005.pub2.

Author Information

  1. 1

    St George's, University of London, Population Health Research Institute, London, UK

  2. 2

    University of Alberta, Department of Oncology, Edmonton, AB, Canada

  3. 3

    Brown University Public Health Program, Center for Evidence-based Medicine, Providence, Rhode Island, USA

*Christopher J Cates, Population Health Research Institute, St George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. ccates@sgul.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 17 OCT 2012

SEARCH

References

References to included reviews

  1. References to included reviews
  2. Additional references
  • Cates Christopher J, Cates Matthew J. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2008, issue 3. [DOI: 10.1002/14651858.CD006363.pub2; CD006363]
  • Cates CJ, Lasserson TJ, Jaeschke R. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2009, issue 3. [DOI: 10.1002/14651858.CD006922.pub2]
  • Cates CJ, Lasserson TJ, Jaeschke R. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2009, issue 2. [DOI: 10.1002/14651858.CD006924.pub2]
  • Cates Christopher J, Lasserson Toby J. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2010, issue 1. [DOI: 10.1002/14651858.CD007694.pub2; CD007694]
  • Cates CJ, Cates MJ. Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2012, issue 4. [DOI: 10.1002/14651858.CD006923.pub3]
  • Cates CJ, LJ. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2012, issue 3. [DOI: 10.1002/14651858.CD007695.pub3]

Additional references

  1. References to included reviews
  2. Additional references
Altman 2003
Anderson 2008
Boushey 1980
Bradburn 2007
Bucher 1997
  • Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683-91.
Castle 1993
  • Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993;306(6884):1034-7.
Cates 2011
Chan 2004
  • Chan A-W, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291(20):2457-65.
Chan 2004a
  • Chan A-W, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. Canadian Medical Association Journal 2004;171(7):735-40.
Chowdhury 2011
Cockcroft 2006
Ducharme 2010
  • Ducharme Francine M, Ni Chroinin M, Greenstone I, Lasserson Toby J. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2010, issue 5. [DOI: 10.1002/14651858.CD005535.pub2]
Ducharme 2011
  • Ducharme Francine M, Lasserson Toby J, Cates Christopher J. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2011, issue 5. [DOI: 10.1002/14651858.CD003137.pub4]
GINA 2011
  • Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Available from: http://www.ginasthma.org/. 2011.
ICH E2A 1995
  • Expert Working Group (Efficacy) of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Clinical safety data management: definitions and standards for expedited reporting. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073087.pdf (accessed July 2012). 1995.
Ioannidis 2001
Ioannidis 2004
  • Ioannidis JPA, Evans SJW, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al. CONSORT Group. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Annals of Internal Medicine 2004;141(10):781-8.
Li 2010
  • Li JS, Qaqundah PY, Weinstein SF, LaForce CF, Ellsworth AV, Ortega HG, et al. Fluticasone propionate/salmeterol combination in children with asthma: Key cardiac and overall safety results. Clinical Research and Regulatory Affairs 2010;27(3):87-95.
Lougheed 2010
  • Lougheed MD, Lemiere C, Dell SD, Ducharme FM, Fitzgerald JM, Leigh R, et al. Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Canadian Respiratory Journal 2010;17(2):57-58.
McMahon 2011
NCT01192178
  • GlaxoSmithKline. A Randomized, Double-Blind, Parallel Group Study of FSC 100/50 and FP 100, both twice daily, in a Pediatric Population during the Fall Viral Season [ADA113872]. http://www.gsk-clinicalstudyregister.com/.
NCT01444430
  • AstraZeneca. A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents. ClinicalTrials.gov 2012 (accessed June 2012).
NCT01462344
  • GlaxoSmithKline. 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old (VESTRI). ClinicalTrials.gov 2012 (accessed 29/06/2012).
NCT01471340
  • Merck. A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3) (SPIRO). ClinicalTrials.gov 2012 (accessed June 2012).
NCT01475721
  • GlaxoSmithKline. SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma. (AUSTRI). ClinicalTrials.gov 2012 (accessed June 2012).
Nelson 2006
  • Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM, SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006;129(1):15-26.
Ni Chroinin 2009
  • Ni Chroinin M, Lasserson Toby J, Greenstone I, Ducharme Francine M. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2009, issue 3. [DOI: 10.1002/14651858.CD007949]
Phillips 1990
  • Phillips GD, Finnerty JP, Holgate ST. Comparative protective effect of the inhaled beta-2-agonist salbutamol (albuterol) on bronchoconstriction provoked by histamine, methacholine, and adenosine 5'-monophosphate in asthma. Journal of Allergy and Clinical Immunology 1990;85(4):755-62.
RevMan 5 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Salpeter 2006
  • Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Annals of Internal Medicine 2006;144(12):904-12.
Senn 1997
  • Senn SJ, Lillienthal J, Patalano F, Till D. An incomplete blocks cross-over in asthma: a case study in collaboration. In: Vollmar J, Hothorn LA editor(s). Cross-over Clinical Trials. Stuttgart: Fischer, 1997:3-26.
Shea 2007
SIGN/BTS 2012
  • Scottish Intercollegiate Guidelines Network/British Thoracic Society. British guideline on the management of asthma: a national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network, 2008 (revised 2012).
Tattersfield 2006
Van Noord 1996
  • Van Noord JA, Smeets JJ, Raaijmakers JAM, Bommer AM, Maesen FPV. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. European Respiratory Journal 1996;9(8):1684-8.
Visual Rx 2012
  • Visual Rx. www.nntonline.net/visualrx/ Accessed June 2012.
Weinberger 2006
Whittington 2004
  • Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363(9418):1341-5.